Request for Covid-19 Impact Assessment of this Report
The regional analysis of global Antiscalants/ Scale inhibitors market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific accounts for the largest share in the global antiscalant/scale inhibitor market due to the growing adoption of antiscalant in the water treatment application. Similarly, Asia Pacific is the fastest growing region in the global antiscalants/ scale inhibitors market owing to the need for water treatment in surrounding rivers, rapid urbanization and rising awareness regarding wastewater treatment in countries like China and India.
Market player included in this report are:
Clariant AG
Kemira OYJ
General Electric Co.
The DOW Chemicalco.
Solvay SA
BASF SE.
Ashland Inc.
BWA Water Additives
Avista Technologies
Ict Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Phosphonates
Carboxylates/Acrylic Antiscalants
Sulfonates
Others
By Application:
Power & construction
Mining
Oil & gas
Water & wastewater treatment
Food & Beverages
Others
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Global Antiscalants/ Scale inhibitors Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Antiscalant/scale inhibitor Market, by Region, 2017-2026 (USD Billion)
1.2.2. Antiscalant/scale inhibitor Market, by Type, 2017-2026 (USD Billion)
1.2.3. Antiscalant/scale inhibitor Market, by Application, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antiscalant/scale inhibitor Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antiscalant/scale inhibitor Market Dynamics
3.1. Antiscalant/scale inhibitor Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Antiscalant/scale inhibitor Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antiscalant/scale inhibitor Market, by Type
5.1. Market Snapshot
5.2. Global Antiscalant/scale inhibitor Market by Type, Performance - Potential Analysis
5.3. Global Antiscalant/scale inhibitor Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
5.4. Antiscalant/scale inhibitor Market, Sub Segment Analysis
5.4.1. Phosphonates
5.4.2. Carboxylates/Acrylic Antiscalants
5.4.3. Sulfonates
5.4.4. Others
Chapter 6. Global Antiscalant/scale inhibitor Market, by Application
6.1. Market Snapshot
6.2. Global Antiscalant/scale inhibitor Market by Application, Performance - Potential Analysis
6.3. Global Antiscalant/scale inhibitor Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
6.4. Antiscalant/scale inhibitor Market, Sub Segment Analysis
6.4.1. Power & construction
6.4.2. Mining
6.4.3. Oil & gas
6.4.4. Water & wastewater treatment
6.4.5. Food & Beverages
6.4.6. Others
Chapter 7. Global Antiscalant/scale inhibitor Market, Regional Analysis
7.1. Antiscalant/scale inhibitor Market, Regional Market Snapshot
7.2. North America Antiscalant/scale inhibitor Market
7.2.1. U.S. Antiscalant/scale inhibitor Market
7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
7.2.1.2. Application breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Antiscalant/scale inhibitor Market
7.3. Europe Antiscalant/scale inhibitor Market Snapshot
7.3.1. U.K. Antiscalant/scale inhibitor Market
7.3.2. Germany Antiscalant/scale inhibitor Market
7.3.3. Rest of Europe Antiscalant/scale inhibitor Market
7.4. Asia-Pacific Antiscalant/scale inhibitor Market Snapshot
7.4.1. China Antiscalant/scale inhibitor Market
7.4.2. India Antiscalant/scale inhibitor Market
7.4.3. Japan Antiscalant/scale inhibitor Market
7.4.4. Rest of Asia Pacific Antiscalant/scale inhibitor Market
7.5. Latin America Antiscalant/scale inhibitor Market Snapshot
7.5.1. Brazil Antiscalant/scale inhibitor Market
7.5.2. Mexico Antiscalant/scale inhibitor Market
7.6. Rest of The World Antiscalant/scale inhibitor Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Clariant AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Kemira OYJ
8.2.3. General Electric Co.
8.2.4. The DOW Chemicalco.
8.2.5. Solvay SA
8.2.6. BASF SE.
8.2.7. Ashland Inc.
8.2.8. BWA Water Additives
8.2.9. Avista Technologies
8.2.10. Ict Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET
TABLE 3. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
TABLE 8. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 9. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL ANTISCALANT/SCALE INHIBITOR MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW ANTISCALANT/SCALE INHIBITOR MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.
Nanomaterials possess nanoscale dimensions ranging from 1 to 100 nanometers. They occur naturally or can be engineered with specific properties such as size, shape, surface, and chemistry. Volcanic ash and forest fibers are some of the examples of natural nano...
Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...